Gamma globulin re-treatment in Kawasaki disease.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 8410524.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We retrospectively reviewed the effects of intravenous gamma-globulin (IVGG) re-treatment of 13 children with Kawasaki disease and persistent or recrudescent fever. Fever and mucocutaneous inflammation resolved within 48 hours in nine patients; fever abated in two other children after a third course of IVGG. We conclude that IVGG re-treatment of Kawasaki disease appears to be safe and may improve the clinical course.
Medical subject headings
- Immunoglobulins, Intravenous
- Mucocutaneous Lymph Node Syndrome